![]() |
Caring for patients with breast cancer from 35 hospitals and hospices across london and the home counties |
Call: 020 7830 2323 Open 9am - 5pm Answerphone at other times |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advocacy
People affected by breast cancer – not only the patient but also family, friends and colleagues – often want to get involved in helping to combat the problem. For example, they may become active in raising breast cancer issues of a medical or social nature, in campaigning for equal access to the best treatment and care, or for more funding for research.
Powerful coalitions have sprung up involving advocates with medical experts, politicians and others. Much progress over the last 20 years in providing factual information and vastly improved diagnosis, treatment and care, has been stimulated by breast cancer advocacy. In the UK, the All Party Parliamentary Group on Breast Cancer, working closely with advocates, has brought about improvements in services which have resulted recently in a significant fall in mortality from breast cancer.
All party parliamentary groups now exist in the European Parliament and in a growing number of countries on the continent, through the efforts and influence of Europa Donna, the European Breast Cancer Coalition.
In the United States, where the concept of breast cancer advocacy originated, the National Breast Cancer Coalition involves thousands of advocates in every state, whose campaigns have not only focused huge US budgetary resources on breast cancer management and research, but also inspired the advocacy movement worldwide.
WOULD YOU LIKE TO GET INVOLVED? You can
|
OTHER TESTIMONIALS “When you came to see me nearly a year ago, I was very receptive to your offers of help. But I could have no idea how much Cancerkin would do for me over this difficult year.” Gillian |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
![]() ![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||